500 Diabetic Patients to be remotely monitored through XTend's Disease Management Program

XTend Medical Corporation (Pink Sheets: XMDC) announced today the company has begun a remote diabetic monitoring program with a target of 500 patients to be part of the initial program.

The program, facilitated through local physicians in Southern California, will remotely monitor diabetic patients through the XTend Medical Disease Management Program. The patients will be able to take their glucose readings and transmit the results to the participating physicians via the Eocene transmitter. Once the glucose meter is cradled to Eocene unit, the plug-in system utilizes a standard phone line to send the encrypted patient data to a central server for review by the physician.  Once the data is reviewed by the physician, then any adjustments inmedication, compliance with testing, and/or any necessary follow-up visits can be relayed immediately to the patient.

"This remote diabetic monitoring program is nothing short of groundbreaking for the company and the medical community. Our system is designed for physicians to be able to closely monitor diabetic patients
from their office while the patients maintain their regular daily lives in their own homes. The patient's data can be securely monitored and any adjustments can be made instantaneously through direct communication with
the patient from a remote location," stated Mr. Paul D. Lisenby, CEO of XTend Medical. Mr. Lisenby further states, "XTend Medical is now poised to implement this system nationwide to any healthcare company looking to
remotely monitor their diabetic patients. Our ability to implement the system very rapidly is now in place. Our revenue projections for 2008 should be attainable now that we've set this program in motion."